Clinical Trial Update: Vaccination of Advanced-Stage Lung Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 vaccination trial in advanced-stage lung cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Arkansas | Conditions: Lung Neoplasms | Phase 1, Phase 2 | Status: WITHDRAWN